Catalent, Inc. (CTLT) said Thursday that it has acquired Micron Technologies, a global provider of particle size engineering technologies.
Micron Technologies currently operates two state-of-the-art facilities, with excellent quality and regulatory compliance records, in Malvern, PA, and in Dartford, U.K., and employs approximately 100 people across both sites.
Catalent will add Micron Technologies' superior particle size engineering capabilities to its industry leading suite of drug delivery and development solutions.
Micron Technologies CEO Joseph Drost will continue to lead this business.
The acquisition is Catalent's second since its IPO in July, and follows the acquisition of Redwood Bioscience, with its SMARTag Antibody-Drug Conjugate technology platform, in October.
For comments and feedback contact: editorial@rttnews.com
Business News